Celera Shares Fall as Earnings Miss Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Celera plummeted more than 20 percent today after the firm yesterday reported a loss for its fourth fiscal quarter and forecast lower revenue than analysts expected for 2009.

The company's shares were trading at $7.26 this afternoon, down 22 percent from yesterday's close of $9.34.

Celera yesterday reported revenues of $47.3 million for the three-month period ended Dec. 27, which was in line with analyst estimates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.